Poseida Therapeutics, Inc. (PSTX)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2024-12-11 | 2024-12-10 | PS Planned sale |
Executive Chairman Executive Director |
30,000
-4.4%
9.46USD 283,866 |
30,000 -4.4% | 9.46 | USD 283,866 | |
| 2024-11-27 | 2024-11-26 | PS Planned sale |
Executive Chairman Executive Director |
30,000
-4.4%
9.27USD 278,100 |
30,000 -4.4% | 9.27 | USD 278,100 | |
| 2022-08-10 | 2022-08-08 | PP Planned purchase |
Executive Chairman Executive Director Large shareholder |
142,857
+20.5%
3.50USD 500,000 |
142,857 +20.5% | 3.50 | USD 500,000 | |
| 2022-08-10 | 2022-08-08 | B Purchase |
Malin Life Sciences Holdings Ltd Large shareholder |
2,150,000
+22.2%
3.50USD 7,525,000 |
2,150,000 +22.2% | 3.50 | USD 7,525,000 | |
| 2022-08-05 | 2022-08-03 | PS Planned sale |
Executive Chairman Executive Director Large shareholder |
160,696
-100.0%
3.69USD 592,808 |
160,696 -100.0% | 3.69 | USD 592,808 | |
| 2022-03-18 | 2022-03-16 | B Purchase |
Chief Operating Officer Officer |
3,000
+5.8%
3.98USD 11,940 |
3,000 +5.8% | 3.98 | USD 11,940 | |
| 2021-12-07 | 2021-12-06 | B Purchase |
Malin Life Sciences Holdings Ltd Large shareholder |
1,828
+0.0%
6.90USD 12,613 |
1,828 +0.0% | 6.90 | USD 12,613 | |
| 2021-12-02 | 2021-12-02 | B Purchase |
Malin Life Sciences Holdings Ltd Large shareholder |
4,296
+0.0%
6.88USD 29,550 |
4,296 +0.0% | 6.88 | USD 29,550 | |
| 2021-12-02 | 2021-12-01 | B Purchase |
Malin Life Sciences Holdings Ltd Large shareholder |
18,365
+0.2%
6.85USD 125,806 |
18,365 +0.2% | 6.85 | USD 125,806 | |
| 2021-12-02 | 2021-11-30 | B Purchase |
Malin Life Sciences Holdings Ltd Large shareholder |
28,592
+0.3%
6.85USD 195,838 |
28,592 +0.3% | 6.85 | USD 195,838 | |
| 2021-11-29 | 2021-11-29 | B Purchase |
Malin Life Sciences Holdings Ltd Large shareholder |
11,057
+0.1%
6.89USD 76,209 |
11,057 +0.1% | 6.89 | USD 76,209 | |
| 2021-11-29 | 2021-11-26 | B Purchase |
Malin Life Sciences Holdings Ltd Large shareholder |
27,251
+0.3%
6.81USD 185,492 |
27,251 +0.3% | 6.81 | USD 185,492 | |
| 2021-11-29 | 2021-11-24 | B Purchase |
Malin Life Sciences Holdings Ltd Large shareholder |
1,054
+0.0%
6.89USD 7,260 |
1,054 +0.0% | 6.89 | USD 7,260 | |
| 2021-11-23 | 2021-11-23 | B Purchase |
Malin Life Sciences Holdings Ltd Large shareholder |
14,625
+0.2%
6.77USD 98,989 |
14,625 +0.2% | 6.77 | USD 98,989 | |
| 2021-11-23 | 2021-11-19 | B Purchase |
Malin Life Sciences Holdings Ltd Large shareholder |
11,104
+0.1%
7.44USD 82,650 |
11,104 +0.1% | 7.44 | USD 82,650 | |
| 2021-11-18 | 2021-11-18 | B Purchase |
Malin Life Sciences Holdings Ltd Large shareholder |
71,312
+0.8%
7.18USD 511,685 |
71,312 +0.8% | 7.18 | USD 511,685 | |
| 2021-11-18 | 2021-11-17 | B Purchase |
Chief Operating Officer Officer |
2,000
+inf%
7.00USD 14,000 |
2,000 +inf% | 7.00 | USD 14,000 | |
| 2021-11-18 | 2021-11-17 | B Purchase |
Malin Life Sciences Holdings Ltd Large shareholder |
280,384
+3.0%
7.21USD 2,021,821 |
280,384 +3.0% | 7.21 | USD 2,021,821 | |
| 2021-11-18 | 2021-11-16 | B Purchase |
Malin Life Sciences Holdings Ltd Large shareholder |
27,680
+0.3%
7.17USD 198,383 |
27,680 +0.3% | 7.17 | USD 198,383 | |
| 2021-11-10 | 2021-11-08 | PS Planned sale |
Chief Executive Officer Executive Director Large shareholder |
9,051
-0.3%
7.09USD 64,172 |
9,051 -0.3% | 7.09 | USD 64,172 | |
| 2021-11-10 | 2021-11-08 | PS Planned sale |
Chief Executive Officer Executive Director Large shareholder |
9,873
-0.3%
7.09USD 70,000 |
9,873 -0.3% | 7.09 | USD 70,000 | |
| 2021-10-05 | 2021-10-01 | PS Planned sale |
Chief Executive Officer Executive Director Large shareholder |
9,579
-0.3%
7.02USD 67,245 |
9,579 -0.3% | 7.02 | USD 67,245 | |
| 2021-10-05 | 2021-10-01 | PS Planned sale |
Chief Executive Officer Executive Director Large shareholder |
10,450
-0.3%
7.02USD 73,359 |
10,450 -0.3% | 7.02 | USD 73,359 | |
| 2021-06-14 | 2021-06-11 | PS Planned sale |
Chief Medical Officer Officer |
4,000
-19.5%
9.44USD 37,747 |
4,000 -19.5% | 9.44 | USD 37,747 | |
| 2021-05-05 | 2021-05-04 | PS Planned sale |
Chief Executive Officer Executive Director Large shareholder |
17,211
-0.5%
8.44USD 145,261 |
17,211 -0.5% | 8.44 | USD 145,261 | |
| 2021-05-05 | 2021-05-04 | PS Planned sale |
Chief Executive Officer Executive Director Large shareholder |
18,775
-0.5%
8.44USD 158,461 |
18,775 -0.5% | 8.44 | USD 158,461 | |
| 2021-05-05 | 2021-05-03 | PS Planned sale |
Chief Executive Officer Executive Director Large shareholder |
8,765
-0.2%
9.01USD 78,973 |
8,765 -0.2% | 9.01 | USD 78,973 | |
| 2021-05-05 | 2021-05-03 | PS Planned sale |
Chief Executive Officer Executive Director Large shareholder |
9,561
-0.2%
9.01USD 86,145 |
9,561 -0.2% | 9.01 | USD 86,145 | |
| 2021-04-05 | 2021-04-05 | PS Planned sale |
Chief Executive Officer Executive Director Large shareholder |
1,483
-0.0%
10.32USD 15,307 |
1,483 -0.0% | 10.32 | USD 15,307 | |
| 2021-04-05 | 2021-04-05 | PS Planned sale |
Chief Executive Officer Executive Director Large shareholder |
26,170
-0.7%
9.63USD 251,886 |
26,170 -0.7% | 9.63 | USD 251,886 | |
| 2021-04-05 | 2021-04-05 | PS Planned sale |
Chief Executive Officer Executive Director Large shareholder |
1,617
-0.0%
10.32USD 16,691 |
1,617 -0.0% | 10.32 | USD 16,691 | |
| 2021-04-05 | 2021-04-05 | PS Planned sale |
Chief Executive Officer Executive Director Large shareholder |
28,549
-0.7%
9.63USD 274,784 |
28,549 -0.7% | 9.63 | USD 274,784 | |
| 2021-04-05 | 2021-04-01 | PS Planned sale |
Chief Executive Officer Executive Director Large shareholder |
27,347
-0.8%
9.55USD 261,284 |
27,347 -0.8% | 9.55 | USD 261,284 | |
| 2021-04-05 | 2021-04-01 | PS Planned sale |
Chief Executive Officer Executive Director Large shareholder |
29,834
-0.8%
9.55USD 285,046 |
29,834 -0.8% | 9.55 | USD 285,046 | |
| 2021-03-03 | 2021-03-02 | PS Planned sale |
Chief Executive Officer Executive Director Large shareholder |
27,290
-0.8%
11.54USD 314,899 |
27,290 -0.8% | 11.54 | USD 314,899 | |
| 2021-03-03 | 2021-03-02 | PS Planned sale |
Chief Executive Officer Executive Director Large shareholder |
29,770
-0.8%
11.54USD 343,516 |
29,770 -0.8% | 11.54 | USD 343,516 | |
| 2021-03-03 | 2021-03-01 | PS Planned sale |
Chief Executive Officer Executive Director Large shareholder |
484
-0.0%
12.12USD 5,866 |
484 -0.0% | 12.12 | USD 5,866 | |
| 2021-03-03 | 2021-03-01 | PS Planned sale |
Chief Executive Officer Executive Director Large shareholder |
27,226
-0.7%
11.66USD 317,455 |
27,226 -0.7% | 11.66 | USD 317,455 | |
| 2021-03-03 | 2021-03-01 | PS Planned sale |
Chief Executive Officer Executive Director Large shareholder |
528
-0.0%
12.12USD 6,399 |
528 -0.0% | 12.12 | USD 6,399 | |
| 2021-03-03 | 2021-03-01 | PS Planned sale |
Chief Executive Officer Executive Director Large shareholder |
29,702
-0.7%
11.66USD 346,325 |
29,702 -0.7% | 11.66 | USD 346,325 | |
| 2021-02-17 | 2021-02-16 | PS Planned sale |
Chief Executive Officer Executive Director Large shareholder |
133,149
-39.9%
10.00USD 1,332,036 |
133,149 -39.9% | 10.00 | USD 1,332,036 | |
| 2021-02-12 | 2021-02-10 | PS Planned sale |
Chief Executive Officer Executive Director Large shareholder |
12,389
-3.6%
10.00USD 123,890 |
12,389 -3.6% | 10.00 | USD 123,890 | |
| 2021-01-25 | 2021-01-21 | PS Planned sale |
Chief Executive Officer Executive Director Large shareholder |
4,462
-1.3%
10.00USD 44,620 |
4,462 -1.3% | 10.00 | USD 44,620 | |
| 2020-07-15 | 2020-07-14 | B Purchase | Non-Executive Director |
250,000
+10.1%
16.00USD 4,000,000 |
250,000 +10.1% | 16.00 | USD 4,000,000 | |
| 2020-07-15 | 2020-07-14 | B Purchase | Non-Executive Director Large shareholder |
10,000
+inf%
16.00USD 160,000 |
10,000 +inf% | 16.00 | USD 160,000 | |
| 2020-07-15 | 2020-07-14 | B Purchase | Non-Executive Director |
10,000
+inf%
16.00USD 160,000 |
10,000 +inf% | 16.00 | USD 160,000 |